Shareholding11 Jun 2026, 10:27 am
Sudhir Sethi Acquires 0.06% Stake in Beryl Drugs
AI Summary
Sudhir Sethi, a promoter of Beryl Drugs Ltd, has acquired 3,482 shares, representing 0.06% of the company's total share capital. This acquisition increases his total shareholding to 504,139 shares, or 9.85% of the total diluted share capital. The transaction was conducted through market purchases. This disclosure is made in compliance with SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
Key Highlights
- Promoter Sudhir Sethi acquired 0.06% stake in Beryl Drugs.
- Acquisition comprises 3,482 equity shares.
- Sethi's total holding now stands at 9.85%.
- Transaction made via market purchases.
- Disclosure filed under SEBI Takeover Regulations.
Price Impact
More from BERLDRG